Ambra BioHealth's Debt - II Round

Ambra BioHealth raised a round of funding on December 12, 2017.

Ambra is focused on the physiologic release of hormones produced by the L-cells in the lower gut. The company targets the L-cells beyond the stomach where L-cell density is greatest. These cells secre…

Articles about Ambra BioHealth's Debt - II Round: